title: [NB 506].
authors.affiliation: Laboratoire de pharmacologie antitumorale du centre Oscar-Lambret, et Inserm U. 524, place de Verdun, 59045 Lille Cedex.
authors.forename: A
authors.initials: A
authors.lastname: Lansiaux
authors.forename: C
authors.initials: C
authors.lastname: Bailly
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D002166:Camptothecin / Q000494:pharmacology; D002227:Carbazoles / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D004351:Drug Resistance; D004354:Drug Screening Assays, Antitumor; D004791:Enzyme Inhibitors / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use; D005960:Glucosides / Q000737:chemistry / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy; D059004:Topoisomerase I Inhibitors
chemical_list: D000970:Antineoplastic Agents; D002227:Carbazoles; D004791:Enzyme Inhibitors; D005960:Glucosides; C092476:NB 506; D059004:Topoisomerase I Inhibitors; D002166:Camptothecin